Viewing Study NCT02858258


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-06 @ 7:33 PM
Study NCT ID: NCT02858258
Status: RECRUITING
Last Update Posted: 2017-12-19
First Post: 2016-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
Sponsor: Prof. Dr. M. Dreyling (co-chairman)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module